Available Tolvaptan Products for Fluid Balance

Tolvaptan represents a selective vasopressin V2-receptor antagonist for managing fluid balance issues. It increases renal free water clearance without significantly affecting electrolyte excretion, helping restore systemic balance.

Tolvaptan

Hormone Therapy

15|30mg

5.02 per tablet

Tolvaptan Info

Clinical Overview of Tolvaptan

Tolvaptan belongs to a group of medicines known as vasopressin V₂-receptor antagonists. By selectively blocking the action of the hormone vasopressin, it influences how the kidneys handle water. This active compound is the core ingredient in products marketed simply as Tolvaptan tablets.

Forms and Products Featuring Tolvaptan

In Singapore, Tolvaptan is supplied as oral tablets that contain a fixed amount of the active substance. Both brand-name and generic versions may be present on the market, each complying with the Health Sciences Authority’s standards for quality and safety. The tablets are typically taken with water, and the packaging includes guidance on storage and handling.

Health Situations Managed with Tolvaptan

  • Autosomal dominant polycystic kidney disease (ADPKD) - the drug can help slow the enlargement of kidney cysts, which may preserve kidney function over time.
  • Hyponatraemia linked to heart failure - by promoting water loss, Tolvaptan assists in correcting low blood-sodium levels that arise from excess fluid retention.
  • Syndrome of inappropriate antidiuretic hormone secretion (SIADH) - the medication encourages the body to excrete free water, aiding the return of normal sodium concentrations.
  • Certain liver-related fluid imbalances - in selected cases, Tolvaptan’s effect on water handling may be employed to manage fluid build-up.

These applications generally involve patients whose bodies retain too much water due to hormonal signals.

How the Substance Works in the Body

Tolvaptan interferes with vasopressin’s binding to receptors in the kidney’s collecting ducts. When this signal is blocked, the ducts become less permeable to water, leading to increased urine output without a large loss of electrolytes. In the context of ADPKD, the reduction in fluid pressure around kidney cells is thought to limit cyst growth.

Safety Profile and Possible Reactions

Common Reactions

  • Thirst or a dry mouth sensation.
  • More frequent urination, especially during the first weeks of use.
  • Mild, temporary changes in liver-enzyme levels that are usually monitored through routine blood tests.

Serious Reactions

  • Marked elevation of liver enzymes that may signal liver injury; medical attention is required if symptoms such as jaundice appear.
  • Significant dehydration or rapid shifts in blood-sodium concentration, which can cause dizziness or confusion.

Contraindications

  • Individuals with severe liver impairment.
  • Pregnant or breastfeeding persons, as the effects on fetal development have not been established.

Interaction Awareness

  • Alcohol can intensify dehydration, so limiting intake is advisable.
  • Strong inhibitors of the CYP3A enzyme (for example, certain antifungal agents) may raise Tolvaptan levels.
  • Concurrent use with other diuretics may increase the risk of low sodium or fluid-balance disturbances.

Detailed interaction tables are available on each specific product’s information sheet.

Practical Points to Remember

Tablets should be stored at room temperature, protected from moisture and direct sunlight. Treatment duration varies: chronic use is common for ADPKD, while short-term courses may be employed for acute hyponatraemia. For detailed usage, dosing, and administration, refer to the specific medication’s clinical information.

Key Terms Explained

  • Vasopressin: a hormone that tells the kidneys to retain water.
  • Antagonist: a substance that blocks a receptor, preventing a hormone’s effect.
  • Cyst: a fluid-filled sac that can develop in organs such as the kidneys.
  • Hyponatraemia: a condition where blood sodium levels fall below normal.
  • Glomerular filtration: the process by which the kidneys filter blood to form urine.

Important Usage Disclosure

This article offers an educational summary of Tolvaptan as an active substance and does not constitute medical advice. Individual medicines containing this ingredient may differ in strength, formulation, and specific instructions. The provider assumes no liability for clinical decisions made based on this overview. Patients should review the labeling of their particular product and seek guidance from a healthcare professional when needed.

Information on Tolvaptan is curated and periodically reviewed using established medical references and prescribing guidelines. Content is intended for general awareness and should be verified with a licensed healthcare professional before use.
Categories